Biodelivery sciences international, inc. (BDSI)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total Revenues

129,898

111,389

97,780

81,630

64,128

55,640

48,865

43,453

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

23,098

21,590

18,348

16,777

16,420

15,783

16,205

16,597

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

13,959

-

7,713

6,859

5,582

4,157

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product royalty revenues

-

-

-

-

-

-

-

-

-

-

-

-

4,373

-

3,111

2,071

2,146

1,406

2,237

2,224

2,647

3,407

2,782

3,625

0

-

0

0

-

-

0

0

-

2,716

2,750

1,836

0

0

0

Research revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

47

0

0

-

-

0

-

-

-

Research and development reimbursements

-

-

-

-

-

-

-

-

-

-

-

-

1,152

-

500

58

138

909

1,554

2,797

5,035

12,712

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

41,759

12,036

12,549

22,873

22,749

23,668

25,228

16,462

6,800

24,371

24,174

38,563

53,446

34,985

33,114

16,820

318

261

0

0

-

0

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

41,984

-

43,824

41,488

38,217

48,231

18,568

19,156

31,308

38,944

40,371

41,544

30,424

11,356

27,233

26,111

39,645

54,542

35,023

35,811

19,551

3,262

3,148

2,701

0

0

0

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

14,353

-

11,615

11,000

9,527

8,101

8,507

7,271

5,337

4,939

2,249

2,429

2,433

2,082

2,493

2,225

1,910

1,910

1,503

2,635

1,834

1,756

1,398

687

0

0

0

Expenses:
Research and development

-

-

0

-

-

4,900

10,790

12,077

12,813

13,000

11,338

13,754

16,172

18,878

18,883

18,954

19,452

20,624

20,437

22,734

26,211

34,285

41,525

51,142

55,917

53,327

52,738

48,898

42,686

35,366

26,984

20,652

18,826

20,805

20,841

16,148

0

0

0

Selling, general and administrative

95,810

86,063

79,891

70,020

62,086

58,602

55,788

57,166

59,115

58,869

55,836

53,023

49,549

49,345

51,107

53,768

54,559

54,685

54,831

47,372

0

-

0

0

-

-

-

0

0

-

9,361

8,962

8,684

7,608

8,382

7,985

0

0

0

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Related party general and administrative, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

89

89

88

81

78

79

0

0

0

Impairment of intangible license

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total Expenses:

95,810

86,063

80,757

71,585

64,505

63,505

66,618

69,283

71,968

71,909

67,174

66,777

65,721

68,223

69,990

72,722

74,011

75,309

74,548

75,778

73,224

72,745

70,306

69,325

69,968

65,676

63,934

60,057

52,951

45,571

36,434

29,704

27,599

28,494

29,302

24,456

0

0

0

Income (loss) from operations

10,990

3,736

-1,325

-6,732

-16,797

-23,648

-33,491

-39,725

-45,446

-29,420

-30,329

-35,483

-38,090

-63,935

-37,781

-42,234

-45,321

-35,179

-64,487

-63,893

-47,253

-38,740

-32,185

-30,209

-41,977

-56,402

-39,195

-36,171

-15,215

7,061

-2,914

3,471

-9,881

-26,987

-27,551

-22,442

0

0

0

Interest expense

17,772

19,040

20,327

21,660

10,248

10,192

9,517

8,843

8,196

8,577

7,446

6,339

5,375

3,267

3,264

3,263

2,876

2,518

2,247

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bargain purchase gain

-

-

-

-

-

-

-

-

-

27,336

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-211

329

296

281

251

222

207

188

211

154

0

0

0

Derivative (loss) gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15,008

-10,241

-5,728

121

3,776

1,169

-2,701

-5,594

-8,439

-2,442

2,083

3,463

1,921

2,755

0

0

0

Other (expense) income, net

3

4

-1

0

-7

-14

-21

-33

0

-

0

0

-

64

-17

-13

-15

25

-307

-303

-291

-295

-21

-59

-163

-210

-184

-132

13

33

74

73

35

10

9

22

0

0

0

Loss before income taxes

-6,779

-15,300

-21,653

-28,392

-27,052

-33,854

-43,015

-48,586

-53,675

-10,687

-10,419

-14,445

-16,052

-67,138

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) income before taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35,814

-34,804

-17,607

1,781

0

0

0

-

-

-

-

-

-

Income tax benefit (expense)

0

-

0

-

-61

13

54

54

74

-15,972

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

85

85

0

-

0

0

-

-

-

-

-

-

-

Net (loss) income

-

-

0

-

-

-

0

-

-

5,285

5,553

1,527

-80

-67,138

-41,025

-45,487

-48,212

-37,672

-73,099

-59,331

0

-

0

0

-

-

-

-

-

-

0

0

0

-

-25,409

-19,510

0

0

0

Beneficial conversion feature of convertible preferred stock

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to common stockholders

-6,506

-15,305

-21,617

-40,851

-39,491

-46,367

-51,310

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

0

0

-

0

0

Basic:
Basic and diluted:
Weighted average common stock shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52,542

-

-

-

-

-

-

-

-

-

-

-

30,071

-

-

-

-

-

-

-0

-

Weighted average common stock shares outstanding, basic (in shares)

97,118

88,038

89,649

83,821

71,344

70,296

64,900

59,400

58,062

55,910

55,604

55,388

54,519

55,123

53,767

53,594

52,230

-

-

52,401

51,908

-

49,555

48,521

44,305

-

38,076

37,998

37,511

-

-

-

29,561

-

-

-

25,105

-

-

Basic and diluted loss per share

-

-

-

-0.13

-

-

-

-0.16

-0.18

-

-

-

-

-

-

-

-

-

-0.39

-0.37

-0.16

-

-0.51

-0.14

-

-

-

-

-0.34

-

-0.58

-

-

-

-

-

-

-

-

Basic earnings (loss) per share (in usd per share)

0.05

-

0.00

-

-0.05

-

-0.29

-

-

-0.31

-0.21

-0.27

0.89

-0.28

-0.30

-0.31

-0.36

-

-

-

-

-

-

-

-0.11

-

-0.49

-0.35

-

-

-

0.13

0.23

-0.11

-0.17

-0.18

-0.36

-

0.03

Diluted:
Weighted average common stock shares outstanding, diluted (in shares)

106,965

-

105,138

-

71,344

-

64,900

-

-

59,184

55,604

55,388

55,431

55,123

53,767

53,594

52,230

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,586

-

-

-

25,105

-

-

Diluted earnings (loss) per share (in usd per share)

0.05

-

0.00

-

-0.05

-

-0.29

-

-

-0.30

-0.21

-0.27

0.87

-0.28

-0.30

-0.31

-0.36

-

-

-

-

-

-

-

-0.11

-

-0.49

-0.35

-

-

-

0.12

0.23

-0.11

-0.17

-0.18

-0.36

-

0.01

Product sales
Total Revenues

125,844

107,888

94,481

78,621

61,331

51,410

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product royalty revenues
Total Revenues

3,902

3,341

3,339

3,026

2,951

3,389

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenues
Total Revenues

152

160

-40

-17

-154

841

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-